A novel role for an old target: CD45 for breast cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel role for an old target: CD45 for breast cancer immunotherapy

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Raiter Annat¹^ORCID,Zlotnik Oran¹²,Lipovetsky Julia¹,Mugami Shany¹,Dar Shira¹,Lubin Ido¹,Sharon Eran²,Cohen Cyrille J.³,Yerushalmi Rinat¹⁴^ORCID

Affiliation:

1. Felsenstein Medical Research Center, Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel

2. Surgery Department, Breast Cancer Unit, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel

3. Laboratory of Tumor Immunotherapy, the Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel

4. Breast Cancer Unit, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel

Funder

Imanu Imunotherapy

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1929725

Reference52 articles.

1. The future of cancer immunotherapy: microenvironment-targeting combinations

2. Immune Escape Mechanisms as a Guide for Cancer Immunotherapy

3. Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy

4. Tumor Evasion from T Cell Surveillance

5. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer;Critical Reviews in Oncology/Hematology;2024-09

2. Deciphering breast cancer cell heterogeneity: a quantum dot-conjugate approach employing MCF-7 and THP-1 co-cultures;New Journal of Chemistry;2024

3. CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy;Annals of Hematology;2023-11-02

4. Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer;Frontiers in Immunology;2023-08-25

5. TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor;OncoImmunology;2023-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3